Tricyclic antidepressants for chronic vomiting in diabetic patients

Digestive Diseases and Sciences

Volumn 52, Issue 2, 2007, Pages 418-424

  Sawhney, Mandeep S ^a   Prakash, Chandra ^a   Lustman, Patrick J ^a,b   Clouse, Ray E ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Division of Gastroenterology   (United States)

Author keywords

Antidepressants; Diabetes; Gastroparesis; Nausea; Vomiting

Indexed keywords

AMITRIPTYLINE; ANTIEMETIC AGENT; DESIPRAMINE; IMIPRAMINE; NORTRIPTYLINE; PROKINETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGITATION; ANTICHOLINERGIC EFFECT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE FREE INTERVAL; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; NEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIEMETICS; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NAUSEA; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VOMITING;

EID: 33846262993     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9378-8     Document Type: Article

References (41)

1. Siddique R, Nguyen M, Farup C (1998) Cost of hospitalization for diabetic patients with vomiting: evidence from a national survey. Gastroenterology 114:A41
2. O'Donovan D, Feinle-Bisset C, Jones K, Horowitz M (2003) Idiopathic and diabetic gastroparesis. Curr Treat Options Gastroenterol 6:299-309
3. Smith DS, Ferris CD (2003) Current concepts in diabetic gastroparesis. Drugs 63:1339-1358
4. Clouse RE, Lustman PJ (2002) Case study: persistent vomiting in a patient with type 2 diabetes. Clin Diabetes 20:39-41
5. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K (1999) Antidepressant therapy for unexplained symptoms and syndromes. J Fam Pract 48:980-990
6. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K (2000) Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108:65-72
7. Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL (2004) Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 20:1253-1269
8. Prakash C, Lustman PJ, Freedland KE, Clouse RE (1998) Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci 43:1951-1956
9. Li BU (2000) Cyclic vomiting syndrome. Curr Treat Options Gastroenterol 3:395-402
10. Prakash C, Staiano A, Rothbaum RJ, Clouse RE (2001) Similarities in cyclic vomiting syndrome across age groups. Am J Gastroenterol 96:684-688
11. Prakash C, Clouse RE (1999) Cyclic vomiting syndrome in adults: Clinical features and response to tricyclic antidepressants. Am J Gastroenterol 94:2855-2860
12. Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M (2001) Predictors of delayed gastric emptying in diabetes. Diabetes Care 24:1264-1269
13. Kendall BJ, Kendall ET, Soykan I, McCallum RW (1997) Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study. J Int Med Res 25:182-189
14. Loo FD, Palmer DW, Soergel KH, Kalbfleisch JH, Wood CM (1984) Gastric emptying in patients with diabetes mellitus. Gastroenterology 86:485-494
15. de Caestecker JS, Ewing DJ, Tothill P, Clarke BF, Heading RC (1989) Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: an eight-week double-blind crossover study. Aliment Pharmacol Ther 3:69-81
16. Brown CK, Khanderia U (1990) Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Clin Pharm 9:357-365
17. Snape WJ Jr, Battle WM, Schwartz SS, Braunstein SN, Goldstein HA, Alavi A (1982) Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. Ann Intern Med 96:444-446
18. Ricci DA, Saltzman MB, Meyer C, Callachan C, McCallum RW (1985) Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol 7:25-32
19. Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, Lindberg G, Konturek J, Nowak T, Quigley EM, Tougas G, Starkebaum W (2003) Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125:421-428
20. Tack J, Bisschops R, Sarnelli G (2004) Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127:1239-1255
21. Talley NJ, Verlinden M, Jones M (2001) Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 96:1422-1428
22. Clouse RE (2006) Management of dyspepsia. In: Wolfe MM, David GL, Farraye FA, Giannella RA, Malagelada J-R, Steer ML (eds) Therapy of digestive disorders, 2nd ed. Elsevier, London (in press).
23. Clouse RE, Lustman PJ (2005) The use of psychopharmacological agents for functional gastrointestinal disorders. Gut 54:1332-1341
24. Hasler WL, Chey WD (2003) Nausea and vomiting. Gastroenterology 125:1860-1867
25. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M(2001) Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161:1989-1996
26. Maleki D, Locke GR 3rd, Camilleri M, Zinsmesiter AR, Yawn BP, Leibson C, Melton LJ 3rd (2000) Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 160:2808-2816
27. Mjornheim AC, Finizia C, Blohme G, Attvall S, Lundell L, Ruth M (2003) Gastrointestinal symptoms in type 1 diabetic patients, as compared to a general population. A questionnaire-based study. Digestion 68:102-108
28. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078
29. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2002) Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 53:1053-1060
30. Lustman PJ, Anderson R, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analyitc review of the literature. Diabetes Care 23:934-942
31. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lustman PJ (2002) Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psych Med 32:235-247
32. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM (2003) Depression and coronary heart disease in women with diabetes. Psychosom Med 65:376-383
33. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241-250
34. Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB (2006) Sertraline for prevention of depression recurrence in diabetes: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63:521-529
35. Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, Sato Y, Suzuki S, Hongo M (2000) Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 49:1255-1260
36. Clouse RE, Lustman PJ (1989) Gastro-intestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 84:868-872
37. Talley NJ, Howell S, Jones MP, Horowitz M (2002) Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 97:3087-3094
38. Gorard DA, Libby GW, Farthing MJ (1995) Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome. Dig Dis Sci 40:86-95
39. Drossman DA, Toner BB, Whitehead WE, et al. (2003) Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders. Gastroenterology 125:19-31
40. Clouse RE (2003) Antidepressants for irritable bowel syndrome. Gut 52:598-599
41. Rohde A, Dembinski J, Dorn C (2003) Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 268:219-221